111 related articles for article (PubMed ID: 10199787)
1. Increased sulfatation of orbital glycosaminoglycans in Graves' ophthalmopathy.
Hansen C; Rouhi R; Förster G; Kahaly GJ
J Clin Endocrinol Metab; 1999 Apr; 84(4):1409-13. PubMed ID: 10199787
[TBL] [Abstract][Full Text] [Related]
2. HPLC glycosaminoglycan analysis in patients with Graves' disease.
Hansen C; Fraiture B; Rouhi R; Otto E; Förster G; Kahaly G
Clin Sci (Lond); 1997 May; 92(5):511-7. PubMed ID: 9176026
[TBL] [Abstract][Full Text] [Related]
3. Glycosaminoglycans in thyroid eye disease.
Kahaly G; Förster G; Hansen C
Thyroid; 1998 May; 8(5):429-32. PubMed ID: 9623737
[TBL] [Abstract][Full Text] [Related]
4. Glycosaminoglycans provide a binding site for thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy.
Marinò M; Lisi S; Pinchera A; Marcocci C; Menconi F; Morabito E; Macchia M; Sellari-Franceschini S; McCluskey RT; Chiovato L
Thyroid; 2003 Sep; 13(9):851-9. PubMed ID: 14588099
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-gamma gene expression in orbital adipose/connective tissues is increased during the active stage of Graves' ophthalmopathy.
Mimura LY; Villares SM; Monteiro ML; Guazzelli IC; Bloise W
Thyroid; 2003 Sep; 13(9):845-50. PubMed ID: 14588098
[TBL] [Abstract][Full Text] [Related]
6. H-magnetic resonance spectroscopy of retrobulbar tissue in Graves ophthalmopathy.
Ohtsuka K; Hashimoto M
Am J Ophthalmol; 1999 Dec; 128(6):715-9. PubMed ID: 10612507
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress and antioxidant activity in orbital fibroadipose tissue in Graves' ophthalmopathy.
Hondur A; Konuk O; Dincel AS; Bilgihan A; Unal M; Hasanreisoglu B
Curr Eye Res; 2008 May; 33(5):421-7. PubMed ID: 18568878
[TBL] [Abstract][Full Text] [Related]
8. [The metabolism of glycosaminoglycans in the course of Graves' disease].
Winsz-Szczotka K; Komosińska-Vassev K; Olczyk K
Postepy Hig Med Dosw (Online); 2006; 60():184-91. PubMed ID: 16618989
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of glycosaminoglycan production in cultured human retroocular fibroblasts.
Korducki JM; Loftus SJ; Bahn RS
Invest Ophthalmol Vis Sci; 1992 May; 33(6):2037-42. PubMed ID: 1582808
[TBL] [Abstract][Full Text] [Related]
10. Identity of dermatan and chondroitin sequences in dermatan sulfate chains determined by using fragmentation with chondroitinases and ion-pair high-performance liquid chromatography.
Karamanos NK; Vanky P; Syrokou A; Hjerpe A
Anal Biochem; 1995 Mar; 225(2):220-30. PubMed ID: 7762784
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptor inhibit IL-1-induced glycosaminoglycan production in cultured human orbital fibroblasts from patients with Graves' ophthalmopathy.
Tan GH; Dutton CM; Bahn RS
J Clin Endocrinol Metab; 1996 Feb; 81(2):449-52. PubMed ID: 8636247
[TBL] [Abstract][Full Text] [Related]
12. Urinary glycosaminoglycans in Graves' ophthalmopathy.
Kahaly G; Schuler M; Sewell AC; Bernhard G; Beyer J; Krause U
Clin Endocrinol (Oxf); 1990 Jul; 33(1):35-44. PubMed ID: 2401097
[TBL] [Abstract][Full Text] [Related]
13. [Detection, localization and modulation of hyaluronic acid/CD44 receptor expression in patients with endocrine orbitopathy].
Heufelder AE; Bahn RS; Boergen KP; Scriba PC
Med Klin (Munich); 1993 Apr; 88(4):181-4, 277. PubMed ID: 8492772
[TBL] [Abstract][Full Text] [Related]
14. [The assessment of urinary glycosaminoglycans (GAG) excretion during therapy of patients with progressive Graves' ophthalmopathy].
Pilarska K; Kulig G; Krzystolik Z
Pol Arch Med Wewn; 2001 Feb; 105(2):139-44. PubMed ID: 11505748
[TBL] [Abstract][Full Text] [Related]
15. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
Salvi M; Bingoye F; Chung F; Wall JR
J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of glycosaminoglycans, chondroitin/dermatan sulfate, hyaluronic acid, heparan sulfate, and keratan sulfate by liquid chromatography-electrospray ionization-tandem mass spectrometry.
Osago H; Shibata T; Hara N; Kuwata S; Kono M; Uchio Y; Tsuchiya M
Anal Biochem; 2014 Dec; 467():62-74. PubMed ID: 25197028
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and Graves' ophthalmopathy: in vitro studies and therapeutic implications.
Bartalena L; Tanda ML; Piantanida E; Lai A
Biofactors; 2003; 19(3-4):155-63. PubMed ID: 14757966
[TBL] [Abstract][Full Text] [Related]
18. Glycosaminoglycan components in duodenum with advancing age and in patients with progressive systemic sclerosis.
Murata K; Sekino T; Ikeda T; Yokoyama Y
Digestion; 1995; 56(3):230-6. PubMed ID: 7657049
[TBL] [Abstract][Full Text] [Related]
19. Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves' ophthalmopathy.
Kumar S; Bahn RS
J Clin Endocrinol Metab; 2003 Sep; 88(9):4246-50. PubMed ID: 12970294
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of t-PA-mediated plasminogen activation by partially defucosylated glycosaminoglycans from the sea cucumber Stichopus japonicus.
Kariya Y; Sakai T; Kaneko T; Suzuki K; Kyogashima M
J Biochem; 2002 Aug; 132(2):335-43. PubMed ID: 12153733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
